Camden National Bank Reduces Stock Position in Pfizer Inc. (NYSE:PFE)

Camden National Bank cut its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 23.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 12,300 shares of the biopharmaceutical company’s stock after selling 3,846 shares during the period. Camden National Bank’s holdings in […]

Related Keywords

United States , ,Morgan Stanley ,Camden National Bank ,Advisors Inc ,Pfizer Inc ,Exchange Commission ,Cantor Fitzgerald ,Lifeplan Financial ,Pfizer ,Clifford Swan Investment Counsel ,Free Report ,National Bank ,Swan Investment Counsel ,Capital Partners ,Plan Financial ,Get Free Report ,Visit Holdingschannel ,Pfizer Daily ,